BIOLINERX     Print Page  Close Window

SEC filings
6-K
BIOLINERX LTD. filed this Form 6-K on 11/21/2017
Entire Document
 

BioLineRx Ltd.
CONDENSED CONSOLIDATED INTERIM STATEMENTS OF FINANCIAL POSITION
(UNAUDITED)

   
December 31,
   
September 30,
 
   
2016
   
2017
 
   
in USD thousands
 
Assets
           
CURRENT ASSETS
           
Cash and cash equivalents
   
2,469
     
6,712
 
Short-term bank deposits
   
33,154
     
48,295
 
Prepaid expenses
   
255
     
282
 
Other receivables
   
223
     
558
 
Total current assets
   
36,101
     
55,847
 
                 
NON-CURRENT ASSETS
               
Long-term prepaid expenses
   
52
     
60
 
Long-term investment
   
-
     
1,000
 
Property and equipment, net
   
2,605
     
2,365
 
Intangible assets, net
   
181
     
6,855
 
Total non-current assets
   
2,838
     
10,280
 
Total assets
   
38,939
     
66,127
 
                 
Liabilities and equity
               
CURRENT LIABILITIES
               
Current maturities of long-term bank loan
   
93
     
93
 
Accounts payable and accruals:
               
Trade
   
2,590
     
4,349
 
Other
   
978
     
1,084
 
Total current liabilities
   
3,661
     
5,526
 
NON-CURRENT LIABILITIES
               
Long-term bank loan, net of current maturities
   
250
     
180
 
Warrants
   
1
     
1,396
 
Total non-current liabilities
   
251
     
1,576
 
COMMITMENTS AND CONTINGENT LIABILITIES
               
Total liabilities
   
3,912
     
7,102
 
                 
EQUITY
               
Ordinary shares
   
1,513
     
2,809
 
Share premium
   
199,567
     
239,606
 
Other comprehensive loss
   
(1,416
)
   
(1,416
)
Capital reserve
   
10,569
     
10,227
 
Accumulated deficit
   
(175,206
)
   
(192,201
)
Total equity
   
35,027
     
59,025
 
Total liabilities and equity
   
38,939
     
66,127
 


7